Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.8136
-0.0294 (-3.49%)
At close: Jun 2, 2026, 4:00 PM EDT
0.8200
+0.0064 (0.79%)
After-hours: Jun 2, 2026, 5:52 PM EDT

Outlook Therapeutics Balance Sheet

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash & Equivalents
7.758.0814.9323.3917.414.48
Cash & Short-Term Investments
7.758.0814.9323.3917.414.48
Cash Growth
2.54%-45.85%-36.19%34.46%20.17%15.49%
Accounts Receivable
2.721.49----
Inventory
3.343.34----
Other Current Assets
7.094.4812.497.5910.127.03
Total Current Assets
20.917.3927.4230.9827.5221.51
Net Property, Plant & Equipment
0.20.230.270.030.070.28
Long-Term Investments
0.470.550.690.790.80.85
Other Long-Term Assets
0.320.420.440.50.130.17
Total Assets
21.8918.5828.8232.328.5322.81
Accounts Payable
13.6410.197.976.573.492.2
Accrued Expenses
9.345.625.094.65.283.58
Current Portion of Long-Term Debt
15.8529.9529.4435.5510.920.9
Current Portion of Leases
0.060.060.0500.040.07
Total Current Liabilities
38.8845.8142.5546.7319.736.75
Long-Term Debt
11.12----10.89
Long-Term Leases
0.160.190.25-00.04
Other Long-Term Liabilities
0.724.7759.10.010.060.52
Total Long-Term Liabilities
124.9659.350.010.0611.45
Total Liabilities
50.8950.77101.946.7419.7918.2
Common Stock
1.050.540.240.132.271.76
Additional Paid-in Capital
603.18572.98469.97453.35415.4345.73
Retained Earnings
-633.22-605.71-543.29-467.92-408.94-342.88
Shareholders' Equity
-28.99-32.19-73.08-14.448.744.61
Total Liabilities & Equity
21.8918.5828.8232.328.5322.81
Total Debt
27.1930.1929.7435.5610.9611.9
Net Cash (Debt)
-19.44-22.11-14.81-12.166.442.57
Net Cash Growth
----150.06%-77.26%
Net Cash Per Share
-0.34-0.64-0.80-0.970.610.34
Book Value
-28.99-32.19-73.08-14.448.744.61
Book Value Per Share
-0.51-0.93-3.94-1.150.820.60
Tangible Book Value
-28.99-32.19-73.08-14.448.744.61
Tangible Book Value Per Share
-0.51-0.93-3.94-1.150.820.60
SEC Filings: 10-K · 10-Q